CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Viridian Therapeutics
Viridian Therapeutics

Viridian Therapeutics

Viridian Therapeutics is a clinical-stage biopharmaceutical company developing IGF-1R therapies for thyroid eye disease.

Legal seat
Waltham, MA, US🇺🇸
Overview
Compare
Employees
Library

Viridian Therapeutics is a biopharmaceutical company based in Waltham, Massachusetts, focused on developing therapies for thyroid eye disease and other autoimmune conditions. Its anti-IGF-1R antibody veligrotug was approved by the FDA in June 2026 under the brand name Lumvoa.

The company is also developing elegrobart, a subcutaneously administered anti-IGF-1R antibody, and reported that its Phase 3 REVEAL-1 trial met its primary endpoint in patients with active thyroid eye disease. Both assets target the same IGF-1R pathway as oral competitors in the indication.

Viridian Therapeutics - Products & Services

  • Elegrobart logo

    Elegrobart

    Elegrobart is Viridian's subcutaneous anti-IGF-1R antibody candidate for thyroid eye disease.

    Competing Products

    Sling Therapeutics logo
  • Lumvoa logo

    Lumvoa

    Lumvoa is Viridian's FDA-approved anti-IGF-1R infusion for thyroid eye disease.

    Competing Products

    Sling Therapeutics logo

Viridian Therapeutics - Similar Companies

Sling Therapeutics logo

Sling Therapeutics

slingtx.com

Crystalys Therapeutics logo

Crystalys Therapeutics

crystalystx.com

Theranica logo

Theranica

theranica.com

Vian Therapeutics logo

Vian Therapeutics

viantx.com

Virsti Therapeutics logo

Virsti Therapeutics

Akebia Therapeutics logo

Akebia Therapeutics

akebia.com

Beeline Medicines logo

Beeline Medicines

Lumeda logo

Lumeda

lumedainc.com

Eirion Therapeutics logo

Eirion Therapeutics

eirionthera.com

Iview Therapeutics logo

Iview Therapeutics

TG Therapeutics logo

TG Therapeutics

tgtherapeutics.com

Visgenx logo

Visgenx

visgenx.com

City Therapeutics logo

City Therapeutics

citytx.com

Virvio logo

Virvio

Vir Biotechnology logo

Vir Biotechnology

vir.bio

Viridian Therapeutics - Quick Facts

Who are Viridian Therapeutics' competitors?

Companies similar to Viridian Therapeutics include Sling Therapeutics, Crystalys Therapeutics, Theranica and Vian Therapeutics.

Viridian Therapeutics - Classification

Tags
  • Therapeutics